Literature DB >> 22434508

Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy.

Tamara O Thomas1, Thomas M Morgan, William B Burnette, Larry W Markham.   

Abstract

Sinus tachycardia is common in cases of Duchenne muscular dystrophy (DMD). The authors hypothesized that an elevated heart rate would herald cardiomyopathy onset. A retrospective case-control study was performed with 55 DMD boys and 150 age-matched control boys. The variables were age, heart rate, shortening fraction, and left ventricular end-diastolic dimension. Cardiomyopathy was defined as a shortening fraction less than 28%. The DMD boys had a higher initial heart rate with no baseline echocardiographic evidence of cardiomyopathy. The control subjects showed a statistically significant age-related decline in heart rate (p = 0.001) but not the DMD boys. Cardiomyopathy developed in 17 of the 55 DMD boys over a period of 4.6 ± 1.6 years. The DMD upper and lower heart rate groups were similar in age, follow-up time, and initial shortening fraction, yet cardiomyopathy developed in 14 (42%) of 33 upper quartile boys but only 3 (14%) of 22 lower quartile DMD boys (odds ratio, 6.5 (95% confidence interval, 1.15-18.92; p < 0.05). Compared with the control subjects, the DMD boys had a higher resting heart rate and a lack of age-related heart rate decline. The DMD boys in the upper heart rate quartile were more likely to progress to cardiomyopathy than those in the lower quartiles. This study establishes heart rate elevation as a statistically significant risk factor for cardiomyopathy. Further studies may define heart rate cutoffs for early pharmacologic intervention for incipient cardiomyopathy.

Entities:  

Mesh:

Year:  2012        PMID: 22434508     DOI: 10.1007/s00246-012-0281-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  23 in total

1.  Cardiac and pulmonary complications in Duchenne's progressive muscular dystrophy.

Authors:  J GILROY; J L CAHALAN; R BERMAN; M NEWMAN
Journal:  Circulation       Date:  1963-04       Impact factor: 29.690

2.  Mechanisms of blood pressure and heart rate variability: an insight from low-level paraplegia.

Authors:  Paolo Castiglioni; Marco Di Rienzo; Arsenio Veicsteinas; Gianfranco Parati; Giampiero Merati
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-11-22       Impact factor: 3.619

3.  Impairment of cardiac autonomic function in patients with Duchenne muscular dystrophy: relationship to myocardial and respiratory function.

Authors:  G A Lanza; A Dello Russo; V Giglio; L De Luca; L Messano; C Santini; E Ricci; A Damiani; G Fumagalli; G De Martino; F Mangiola; F Bellocci
Journal:  Am Heart J       Date:  2001-05       Impact factor: 4.749

4.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

5.  Heart rate variability is altered following spinal cord injury.

Authors:  D C Bunten; A L Warner; S R Brunnemann; J L Segal
Journal:  Clin Auton Res       Date:  1998-12       Impact factor: 4.435

6.  Steroid therapy and cardiac function in Duchenne muscular dystrophy.

Authors:  L W Markham; R L Spicer; P R Khoury; B L Wong; K D Mathews; L H Cripe
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

7.  Histopathological study of the conduction system of the heart in Duchenne progressive muscular dystrophy.

Authors:  H Nomura; K Hizawa
Journal:  Acta Pathol Jpn       Date:  1982-11

8.  Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy.

Authors:  Larry W Markham; Kathi Kinnett; Brenda L Wong; D Woodrow Benson; Linda H Cripe
Journal:  Neuromuscul Disord       Date:  2008-04-23       Impact factor: 4.296

9.  Autonomic function and the sinus tachycardia of Duchenne muscular dystrophy.

Authors:  G Miller; L D'Orsogna; J P O'Shea
Journal:  Brain Dev       Date:  1989       Impact factor: 1.961

10.  Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy.

Authors:  Giovanni Corrado; Alberto Lissoni; Sandro Beretta; Laura Terenghi; Giorgio Tadeo; Giovanni Foglia-Manzillo; Luca M Tagliagambe; Manuela Spata; Mauro Santarone
Journal:  Am J Cardiol       Date:  2002-04-01       Impact factor: 2.778

View more
  20 in total

1.  Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?

Authors:  Tamara O Thomas; John L Jefferies; Angela Lorts; Jeffrey B Anderson; Zhiqian Gao; D Woodrow Benson; Kan N Hor; Linda H Cripe; Elaine M Urbina
Journal:  Pediatr Cardiol       Date:  2014-11-16       Impact factor: 1.655

2.  Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

Authors:  Elizabeth M McNally; Jonathan R Kaltman; D Woodrow Benson; Charles E Canter; Linda H Cripe; Dongsheng Duan; Jonathan D Finder; William J Groh; Eric P Hoffman; Daniel P Judge; Naomi Kertesz; Kathi Kinnett; Roxanne Kirsch; Joseph M Metzger; Gail D Pearson; Jill A Rafael-Fortney; Subha V Raman; Christopher F Spurney; Shari L Targum; Kathryn R Wagner; Larry W Markham
Journal:  Circulation       Date:  2015-05-05       Impact factor: 29.690

Review 3.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

4.  Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies.

Authors:  Christopher F Spurney; Francis M McCaffrey; Avital Cnaan; Lauren P Morgenroth; Sunil J Ghelani; Heather Gordish-Dressman; Adrienne Arrieta; Anne M Connolly; Timothy E Lotze; Craig M McDonald; Robert T Leshner; Paula R Clemens
Journal:  J Am Soc Echocardiogr       Date:  2015-04-21       Impact factor: 5.251

5.  Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy.

Authors:  Heirim Lee; Jinyoung Song; I-Seok Kang; June Huh; Jin A Yoon; Yong Beom Shin
Journal:  Clin Exp Pediatr       Date:  2022-08-22

Review 6.  Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations.

Authors:  John Bourke; Cathy Turner; William Bradlow; Ashish Chikermane; Caroline Coats; Matthew Fenton; Maria Ilina; Alexandra Johnson; Stam Kapetanakis; Lisa Kuhwald; Adrian Morley-Davies; Ros Quinlivan; Konstantinos Savvatis; Marianela Schiava; Zaheer Yousef; Michela Guglieri
Journal:  Open Heart       Date:  2022-10

7.  Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy.

Authors:  Ying Li; Shuai Zhang; Xiaoying Zhang; Jing Li; Xiaojie Ai; Li Zhang; Daohai Yu; Shuping Ge; Yizhi Peng; Xiongwen Chen
Journal:  Cardiovasc Res       Date:  2014-05-08       Impact factor: 10.787

8.  Does Body Mass Index Predict Premature Cardiomyopathy Onset for Duchenne Muscular Dystrophy?

Authors:  Meghann McKane; Jonathan H Soslow; Meng Xu; Benjamin R Saville; James C Slaughter; W Bryan Burnette; Larry W Markham
Journal:  J Child Neurol       Date:  2017-01-13       Impact factor: 1.987

9.  Reduced Myocardial Reserve in Young X-Linked Muscular Dystrophy Mice Diagnosed by Two-Dimensional Strain Analysis Combined with Stress Echocardiography.

Authors:  Zhenzhou Li; Ying Li; Li Zhang; Xiaoying Zhang; Rebecca Sullivan; Xiaojie Ai; Christopher Szeto; Angela Cai; Longjian Liu; Weidong Xiao; Quanshui Li; Shuping Ge; Xiongwen Chen
Journal:  J Am Soc Echocardiogr       Date:  2017-05-13       Impact factor: 5.251

10.  Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy.

Authors:  Peggy P Ho; Lauren J Lahey; Foteini Mourkioti; Peggy E Kraft; Antonio Filareto; Moritz Brandt; Klas E G Magnusson; Eric E Finn; Jeffrey S Chamberlain; William H Robinson; Helen M Blau; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-04       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.